Bradley D J, Bannister B
HPA Malaria Reference Laboratory, London School of Hygiene and Tropical Medicine, London.
Commun Dis Public Health. 2003 Sep;6(3):180-99.
This updated guidance from the Advisory Committee on Malaria Prevention for UK Travellers provides the essential information for healthcare workers who advise travellers. The many personal, visit and location-specific factors that need to be taken into account are discussed. Tables include the available antimalarials for prophylaxis and for standby treatment, appropriate choices of regimen by region and country for malarious areas, and the adjustments needed for children and in concomitant disease. There is greater emphasis on mefloquine, doxycycline and atovaquone/proguanil as the three options for highly chloroquine-resistant falciparum malarious areas, and changes in emergency standby medication.
英国旅行者疟疾预防咨询委员会的这份最新指南为为旅行者提供建议的医护人员提供了重要信息。文中讨论了许多需要考虑的个人、出行及特定地点因素。表格包括用于预防和备用治疗的现有抗疟药、按地区和国家针对疟疾流行地区的适当治疗方案选择,以及儿童和合并疾病时所需的调整。对于高度耐氯喹的恶性疟流行地区,更强调将甲氟喹、多西环素和阿托伐醌/氯胍作为三种选择,以及紧急备用药物的变化。